Investigational Drug Information for PF-04457845
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for PF-04457845?
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Osteoarthritis, Knee, and Osteoarthritis. The leading clinical trial sponsors are Pfizer, Yale University, and National Institute on Drug Abuse (NIDA).
Summary for PF-04457845
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2009-11-01) |
| Vendors | 47 |
Recent Clinical Trials for PF-04457845
| Title | Sponsor | Phase |
|---|---|---|
| A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder | Pfizer | Phase 2 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Tourette Association of America | Phase 1 |
| FAAH Inhibitor Trial for Adults With Tourette Syndrome | Yale University | Phase 1 |
Clinical Trial Summary for PF-04457845
Top disease conditions for PF-04457845
Top clinical trial sponsors for PF-04457845
US Patents for PF-04457845
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
